Research |
![]() ![]() ![]() ![]() ![]() |
Serial Number | 87002958 |
Registration Number | 5263499 |
Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
Domestic Representative | Nicole K. McLaughlin, Esquire |
Attorney Name | Nicole K. McLaughlin, Esquire |
Attorney Docket Number | E6889-00038 |
Law Office Assigned | N10 |
Employee Name | CROWLEY, PAUL C |
2016-04-15 | Application Filed |
2017-05-30 | Published for Opposition |
2017-08-15 | Location: PUBLICATION AND ISSUE SECTION |
2017-08-15 | Status: Live/Registered |
2017-08-15 | Trademark Registered |
2018-07-08 | Transaction Date |
Owner: | ![]() |
Entity Statement | limited company |
Address | Cardiff Medicentre, Heath Park Cardiff GB CF144UJ |
Legal Entity Type | |
Legal Entity State | GB |
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
International Codes: | 5 |
U.S. Codes: | 006,018,044,046,051,052 |
Type Code | Type |
---|---|
GS0051 | Pharmaceutical preparations and substances for use in the treatment of adrenal insufficiency and congenital adrenal hyperplasia for medical and veterinary use |
Description | Date | Event Coding |
---|---|---|
NEW APPLICATION ENTERED IN TRAM | 2016-04-19 | 1 NWAP I:Incoming Correspondence |
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2016-04-20 | 2 NWOS I:Incoming Correspondence |
ASSIGNED TO EXAMINER | 2016-08-01 | 3 DOCK D:Assigned to Examiner |
SUSPENSION LETTER WRITTEN | 2016-08-02 | 4 CNSL R:Renewal |
LETTER OF SUSPENSION E-MAILED | 2016-08-02 | 5 GNSL F:First Action |
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | 2016-08-02 | 6 GNS3 O:Outgoing Correspondence |
ASSIGNED TO LIE | 2017-02-15 | 7 ALIE A:Allowance for Publication |
LIE CHECKED SUSP - TO ATTY FOR ACTION | 2017-02-15 | 8 RCCK S: |
SUSPENSION INQUIRY WRITTEN | 2017-02-21 | 9 CNSI R:Renewal |
INQUIRY TO SUSPENSION E-MAILED | 2017-02-21 | 10 GNSI S: |
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | 2017-02-21 | 11 GNS2 O:Outgoing Correspondence |
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | 2017-03-27 | 12 ERSI I:Incoming Correspondence |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 2017-04-01 | 13 CRFA I:Incoming Correspondence |
TEAS/EMAIL CORRESPONDENCE ENTERED | 2017-04-01 | 14 TEME I:Incoming Correspondence |
EXAMINERS AMENDMENT -WRITTEN | 2017-04-18 | 15 CNEA R:Renewal |
EXAMINERS AMENDMENT E-MAILED | 2017-04-18 | 16 GNEA O:Outgoing Correspondence |
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | 2017-04-18 | 17 GNEN O:Outgoing Correspondence |
EXAMINER'S AMENDMENT ENTERED | 2017-04-18 | 18 XAEC I:Incoming Correspondence |
APPROVED FOR PUB - PRINCIPAL REGISTER | 2017-04-18 | 19 CNSA O:Outgoing Correspondence |
LAW OFFICE PUBLICATION REVIEW COMPLETED | 2017-04-21 | 20 PREV O:Outgoing Correspondence |
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2017-05-10 | 21 NONP E:E-Mail |
PUBLISHED FOR OPPOSITION | 2017-05-30 | 22 PUBO A:Allowance for Publication |
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2017-05-30 | 23 NPUB E:E-Mail |
REGISTERED-PRINCIPAL REGISTER | 2017-08-15 | 24 R.PR A:Allowance for Publication |
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | 2022-08-15 | 25 REM1 E:E-Mail |
TEAS SECTION 8 RECEIVED | 2022-12-21 | 26 ES8R I:Incoming Correspondence |
CASE ASSIGNED TO POST REGISTRATION PARALEGAL | 2023-06-16 | 27 APRE A:Allowance for Publication |
REGISTERED - SEC. 8 (6-YR) ACCEPTED | 2023-06-16 | 28 8.OK O:Outgoing Correspondence |
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED | 2023-06-16 | 29 NAS8 E:E-Mail |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.